nearli
criteria
pneumonia
infect
pulmonari
parenchyma
must
consid
one
import
categori
diseas
affect
respiratori
system
note
pneumonia
extraordinarili
common
common
reason
hospit
admiss
unit
state
women
give
birth
mortal
higher
admit
diagnosi
pneumonia
adult
year
age
unit
state
top
admit
diagnos
pneumonia
aggreg
cost
nearli
billion
million
hospit
stay
unit
state
world
lead
caus
death
among
children
year
age
common
reason
children
hospit
unit
state
worldwid
pneumonia
afflict
estim
million
peopl
per
year
result
million
death
wonder
sir
william
osler
refer
pneumonia
captain
men
death
particularli
spoke
era
effect
antibiot
therapi
mani
type
pneumonia
medic
therapi
antibiot
along
support
care
great
impact
durat
outcom
ill
effect
treatment
diseas
discuss
chapter
typic
gratifi
treat
involv
medic
personnel
unfortun
emerg
trend
past
year
acquisit
antibiot
resist
organ
caus
pneumonia
treatment
pneumonia
evolv
keep
pace
although
mani
specif
agent
caus
pneumonia
consid
chapter
organ
primarili
gener
discuss
clinic
problem
pneumonia
appropri
focu
individu
etiolog
agent
highlight
characterist
featur
particularli
use
physician
also
cover
commonli
use
categor
pneumonia
base
clinic
set
communityacquir
versu
nosocomi
hospitalacquir
pneumonia
current
clinic
practic
approach
evalu
manag
two
type
pneumonia
often
quit
differ
chapter
conclud
brief
discuss
sever
infect
uncommon
primarili
histor
interest
recent
threat
bioterror
emerg
addit
review
inhal
anthrax
chapter
briefli
describ
two
organ
consid
concern
potenti
weapon
bioterror
yersinia
pesti
caus
plagu
francisella
tularensi
caus
tularemia
host
defens
lung
constantli
challeng
varieti
organ
includ
virus
bacteria
see
chapter
virus
particular
like
avoid
overwhelm
upper
respiratori
tract
defens
caus
transient
rel
mild
clinic
ill
symptom
limit
upper
respiratori
tract
host
defens
mechan
upper
lower
respiratori
tract
overwhelm
microorgan
may
establish
resid
prolifer
caus
frank
infecti
process
within
pulmonari
parenchyma
particularli
virul
organ
major
impair
host
defens
mechan
need
pneumonia
may
occur
even
normal
otherwis
healthi
individu
extrem
host
defens
mechan
quit
impair
microorgan
particularli
virul
unlik
caus
diseas
healthi
host
may
produc
lifethreaten
pneumonia
practic
sever
factor
frequent
caus
enough
impair
host
defens
contribut
develop
pneumonia
even
though
individu
impair
consid
immunosuppress
viral
upper
respiratori
tract
infect
ethanol
abus
cigarett
smoke
heart
failur
preexist
chronic
obstruct
pulmonari
diseas
copd
contribut
factor
sever
impair
host
defens
caus
diseas
associ
immunosuppress
eg
advanc
aid
variou
underli
malign
particularli
leukemia
lymphoma
use
corticosteroid
immunosuppress
drug
case
associ
impair
host
defens
individu
suscept
bacteri
unusu
nonbacteri
infect
see
chapter
microorgan
especi
bacteria
find
way
lower
respiratori
tract
two
major
way
first
inhal
wherebi
organ
usual
carri
small
droplet
particl
inhal
tracheobronchi
tree
second
aspir
wherebi
secret
oropharynx
pass
larynx
tracheobronchi
tree
aspir
usual
thought
process
occur
individu
unabl
protect
airway
secret
glottic
closur
cough
although
clinic
signific
aspir
like
occur
individu
everyon
subject
aspir
small
amount
oropharyng
secret
particularli
sleep
defens
mechan
seem
abl
cope
nightli
onslaught
bacteria
frequent
bout
aspir
pneumonia
experienc
less
commonli
bacteria
reach
pulmonari
parenchyma
bloodstream
rather
airway
rout
import
spread
certain
organ
particularli
staphylococcu
pneumonia
result
way
bacteremia
implic
distant
primari
sourc
bacteri
infect
present
bacteria
introduc
directli
bloodstream
eg
intraven
drug
use
mani
individu
infecti
agent
associ
develop
pneumonia
frequenc
agent
involv
difficult
assess
depend
larg
extent
specif
popul
studi
largest
singl
categori
agent
probabl
bacteria
two
major
categori
virus
mycoplasma
bacteria
organ
frequent
associ
pneumonia
streptococcu
pneumonia
common
parlanc
often
call
pneumococcu
estim
adult
approxim
onehalf
pneumonia
seriou
enough
requir
hospit
caus
pneumonia
pneumonia
normal
inhabit
oropharynx
larg
proport
adult
gramposit
coccu
typic
seen
pair
diplococci
pneumococc
pneumonia
commonli
acquir
commun
ie
nonhospit
patient
frequent
occur
follow
viral
upper
respiratori
tract
infect
organ
polysaccharid
capsul
interfer
immun
recognit
phagocytosi
therefor
import
factor
virul
mani
differ
antigen
type
capsular
polysaccharid
host
defens
cell
phagocyt
organ
antibodi
particular
capsular
type
must
present
antibodi
contribut
way
phagocyt
process
call
opsonin
see
chapter
staphylococcu
aureu
anoth
gramposit
coccu
usual
appear
cluster
examin
microscop
three
major
set
organ
seen
caus
pneumonia
secondari
complic
respiratori
tract
infect
influenza
viru
hospit
patient
often
impair
host
defens
mechan
whose
oropharynx
colon
staphylococcu
complic
widespread
dissemin
staphylococc
organ
bloodstream
varieti
gramneg
organ
potenti
caus
pneumonia
import
exampl
group
organ
mention
haemophilu
influenza
small
coccobacillari
gramneg
organ
often
found
nasopharynx
normal
individu
lower
airway
patient
copd
caus
pneumonia
children
adultsth
latter
often
underli
copd
predispos
factor
klebsiella
pneumonia
rel
larg
gramneg
rod
normal
found
gastrointestin
tract
best
describ
caus
pneumonia
set
underli
alcohol
pseudomona
aeruginosa
found
varieti
environment
sourc
includ
hospit
environ
seen
primarili
patient
debilit
hospit
often
previous
treat
antibiot
p
aeruginosa
also
common
caus
respiratori
tract
infect
patient
underli
bronchiectasi
cystic
fibrosi
bacteri
flora
normal
present
mouth
potenti
etiolog
agent
develop
pneumonia
multitud
organ
gramposit
gramneg
favor
requir
anaerob
condit
growth
major
organ
compris
mouth
flora
common
predispos
factor
anaerob
pneumonia
aspir
secret
oropharynx
tracheobronchi
tree
patient
impair
conscious
eg
result
coma
alcohol
drug
ingest
seizur
difficulti
swallow
eg
result
stroke
diseas
caus
muscl
weak
prone
aspir
greatest
risk
pneumonia
caus
anaerob
mix
mouth
organ
addit
patient
poor
dentit
gum
diseas
like
develop
aspir
pneumonia
larger
burden
organ
oral
caviti
set
prolong
hospit
recent
use
antibiot
type
bacteria
resid
oropharynx
may
chang
specif
aerob
gramneg
bacilli
aureu
like
colon
oropharynx
subsequ
pneumonia
result
aspir
oropharyng
content
may
includ
aerob
organ
part
process
two
final
type
bacteria
mention
recent
addit
list
etiolog
agent
first
organ
legionella
pneumophila
identifi
caus
mysteri
outbreak
pneumonia
affect
american
legion
member
convent
philadelphia
sinc
recogn
import
caus
pneumonia
occur
epidem
well
isol
sporad
case
seem
affect
previous
healthi
individu
prior
impair
respiratori
defens
mechan
retrospect
sever
prior
outbreak
unexplain
pneumonia
shown
due
organ
although
organ
technic
gramneg
bacillu
poorli
visual
convent
stain
method
organ
chlamydophila
pneumonia
recogn
epidemiolog
studi
caus
approxim
case
pneumonia
appear
relat
gramneg
bacteria
part
life
cycl
oblig
intracellular
parasit
diagnosi
rare
made
clinic
lack
distinguish
clinic
radiograph
featur
organ
readili
cultur
result
serolog
studi
serv
primari
mean
diagnosi
although
infrequ
obtain
may
difficult
interpret
mani
type
bacteria
caus
pneumonia
cover
chapter
interest
reader
consult
detail
public
list
refer
end
chapter
although
virus
extrem
common
caus
upper
respiratori
tract
infect
diagnos
rel
infrequ
caus
frank
pneumonia
except
children
adult
influenza
viru
commonli
diagnos
agent
influenza
pandem
fortun
caus
fewer
death
origin
anticip
rais
profil
best
practic
prevent
diagnosi
treatment
viru
contrast
influenza
pandem
estim
result
million
death
world
popul
outbreak
pneumonia
caus
adenoviru
also
well
describ
particularli
among
militari
recruit
rel
rare
caus
fulmin
often
lethal
pneumonia
describ
southwest
unit
state
case
locat
also
recogn
speci
hantaviru
genu
virus
respons
pneumonia
found
rodent
previous
describ
caus
fever
hemorrhag
acut
renal
failur
part
world
sever
virus
caus
limit
epidem
sever
viral
pneumonia
recent
year
outbreak
novel
highli
contagi
highli
lethal
pneumonia
report
east
asia
canada
outbreak
term
sever
acut
respiratori
syndrom
sar
attribut
novel
coronaviru
may
evolv
type
normal
found
civet
weasellik
mammal
found
chines
market
middl
east
respiratori
syndrom
mer
coronaviru
caus
outbreak
sever
pneumonia
nearli
mortal
rate
caus
agent
relat
viru
normal
infect
camel
case
trace
initi
exposur
arabian
peninsula
mycoplasma
appear
class
organ
intermedi
virus
bacteria
unlik
bacteria
rigid
cell
wall
unlik
virus
requir
intracellular
machineri
host
cell
replic
capabl
freeliv
growth
similar
size
larg
virus
mycoplasma
smallest
fulli
freeliv
organ
identifi
thu
far
organ
recogn
common
caus
pneumonia
perhap
respons
minimum
case
mycoplasm
pneumonia
occur
frequent
young
adult
limit
age
group
pneumonia
gener
acquir
communitythat
previous
healthi
nonhospit
individualsand
may
occur
either
isol
case
local
outbreak
patholog
process
common
pneumonia
infect
inflamm
distal
pulmonari
parenchyma
influx
polymorphonuclear
leukocyt
pmn
edema
fluid
erythrocyt
mononuclear
cell
fibrin
develop
variabl
extent
case
bacteri
pneumonia
particular
character
exuber
outpour
pmn
alveolar
space
attempt
limit
prolifer
invad
bacteria
individu
type
pneumonia
may
differ
exact
locat
mode
spread
infect
past
distinct
often
made
pneumonia
follow
lobar
distribut
behav
like
bronchopneumonia
pattern
interstiti
pneumonia
howev
distinct
often
difficult
make
individu
case
pneumonia
frequent
adher
one
particular
pattern
mixtur
three
pattern
vari
proport
given
limit
brief
mention
three
major
type
follow
lobar
pneumonia
lobar
pneumonia
classic
describ
process
limit
segment
boundari
rather
tend
spread
throughout
entir
lobe
lung
spread
infect
believ
occur
alveolu
alveolu
acinu
acinu
interalveolar
pore
known
pore
kohn
classic
exampl
lobar
pneumonia
due
pneumonia
although
mani
case
pneumonia
document
due
pneumococcu
necessarili
follow
typic
pattern
bronchopneumonia
bronchopneumonia
distal
airway
inflamm
promin
along
alveolar
diseas
spread
infect
inflammatori
process
tend
occur
airway
rather
adjac
alveoli
acini
wherea
lobar
pneumonia
appear
dens
consolid
involv
part
lobe
bronchopneumonia
patchi
distribut
depend
spread
airway
occur
mani
bacteria
staphylococci
varieti
gramneg
bacilli
may
produc
patchi
pattern
interstiti
pneumonia
interstiti
pneumonia
character
inflammatori
process
within
interstiti
wall
rather
alveolar
space
although
viral
pneumonia
classic
start
interstiti
pneumonia
sever
case
gener
show
extens
inflammatori
process
alveolar
space
well
case
pneumonia
organ
highli
destruct
lung
tissu
even
though
exuber
inflammatori
process
may
seen
pneumococc
pneumonia
classic
although
alway
behav
way
heal
process
associ
restor
rel
normal
parenchym
architectur
case
organ
destruct
tissu
necrosi
may
occur
result
caviti
format
scar
parenchyma
mani
case
staphylococc
anaerob
pneumonia
follow
destruct
cours
infect
pulmonari
parenchyma
produc
clinic
sequela
alter
normal
function
lung
parenchyma
also
induc
gener
system
respons
invad
microorgan
major
pathophysiolog
consequ
inflamm
infect
involv
distal
air
space
decreas
ventil
affect
area
perfus
rel
maintain
often
vasodilatori
effect
inflammatori
mediat
ventilationperfus
mismatch
result
low
ventilationperfus
ratio
diseas
region
alveoli
total
fill
inflammatori
exud
may
ventil
region
extrem
ventilationperfus
inequ
ie
shunt
result
ventilationperfus
inequ
gener
manifest
hypoxemia
although
shunt
may
explain
part
hypoxemia
ventilationperfus
mismatch
area
low
ventilationperfus
ratio
usual
import
factor
carbon
dioxid
retent
featur
pneumonia
unless
patient
alreadi
extrem
limit
reserv
especi
underli
copd
fact
patient
pneumonia
frequent
hyperventil
pco
less
mm
hg
system
respons
pneumonia
uniqu
rather
reflect
bodi
respons
seriou
infect
perhap
appar
aspect
respons
fever
outpour
pmn
circul
particularli
bacteri
pneumonia
often
toxic
appear
patient
indirect
system
respons
clue
infecti
process
caus
new
pulmonari
infiltr
mani
way
clinic
manifest
pneumonia
similar
even
differ
infecti
agent
involv
way
present
manifest
quit
differ
although
recognit
subtl
clinic
differ
sometim
allow
astut
clinician
suggest
etiolog
diagnosi
method
identifi
specif
infecti
agent
requir
definit
final
diagnosi
howev
mani
case
specif
agent
clearli
identifi
patient
often
manag
empir
way
base
set
present
perhap
import
constel
symptom
almost
type
pneumonia
consist
fever
cough
often
short
breath
cough
nonproduct
case
particularli
pneumonia
due
virus
mycoplasma
other
especi
bacteri
pneumonia
sputum
product
promin
featur
inflammatori
process
pulmonari
parenchyma
extend
pleural
surfac
patient
often
report
pleurit
chest
pain
fever
high
spike
patient
frequent
experi
shake
chill
associ
rapid
rise
bodi
temperatur
physic
examin
reflect
system
respons
infect
ongo
inflammatori
process
lung
patient
often
tachycardia
tachypnea
fever
examin
chest
typic
reveal
crackl
rale
overli
region
pneumonia
dens
consolid
present
bronchu
suppli
area
patent
sound
transmiss
greatli
increas
consolid
pneumon
area
result
breath
sound
may
increas
bronchial
qualiti
fremitu
increas
egophoni
present
consolid
area
characterist
dull
percuss
overli
chest
wall
examin
peripher
blood
gener
show
increas
white
blood
cell
count
leukocytosi
especi
patient
bacteri
pneumonia
leukocytosi
compos
primarili
pmn
shift
toward
greater
number
immatur
neutrophil
band
form
may
seen
pneumococc
pneumonia
onset
clinic
ill
often
rel
abrupt
sudden
develop
shake
chill
high
fever
cough
may
product
yellow
green
bloodting
rustycolor
sputum
develop
pneumonia
patient
often
experienc
viral
upper
respiratori
tract
infect
import
predispos
featur
mycoplasm
pneumonia
contrast
pneumococc
pneumonia
characterist
somewhat
slower
insidi
onset
cough
particularli
promin
symptom
often
nonproduct
fever
high
shake
chill
uncommon
young
adult
individu
like
mycoplasm
pneumonia
although
diseas
limit
age
group
patient
either
staphylococc
gramneg
bacillari
pneumonia
often
quit
ill
frequent
patient
complex
underli
medic
problem
alreadi
hospit
mani
impair
defens
mechan
recent
receiv
antibiot
staphylococc
pneumonia
classic
may
seen
secondari
complic
influenza
infect
result
dissemin
organ
bloodstream
pneumonia
anaerob
organ
gener
occur
patient
impair
conscious
difficulti
swallow
adequ
protect
airway
aspir
oropharyng
secret
dentit
often
poor
patient
frequent
gingiv
periodont
abscess
clinic
onset
pneumonia
tend
gradual
sputum
may
particularli
foul
odor
suggest
anaerob
infect
success
cultur
caus
organ
may
difficult
gener
slow
grow
anaerob
organ
caus
substanti
tissu
destruct
necrosi
affect
tissu
abscess
format
rel
common
sequela
pneumonia
caus
l
pneumophila
commonli
call
legionnair
diseas
seen
isol
case
local
outbreak
otherwis
healthi
host
may
affect
patient
impair
respiratori
defens
mechan
appear
predispos
patient
often
extrem
ill
respiratori
compromis
even
respiratori
failur
also
nonrespiratori
manifest
specif
gastrointestin
central
nervou
system
hepat
renal
abnorm
may
accompani
pneumonia
disord
affect
pulmonari
parenchyma
singl
use
tool
assess
pneumonia
macroscop
level
chest
radiograph
posteroanterior
later
view
radiograph
confirm
presenc
pneumonia
also
show
distribut
extent
diseas
sometim
give
clue
natur
etiolog
agent
classic
pattern
pneumonia
pneumococcu
k
pneumonia
lobar
pneumonia
fig
staphylococc
mani
gramneg
pneumonia
may
local
extens
often
follow
patchi
distribut
fig
mycoplasma
organ
produc
varieti
radiograph
present
classic
describ
impress
clinic
pictur
would
suggest
pneumonia
caus
aspir
oropharyng
secret
characterist
involv
depend
region
lung
lower
lobe
upright
patient
posterior
segment
upper
lobe
superior
segment
lower
lobe
supin
patient
fig
legionella
pneumonia
commonli
present
patchi
consolid
unilobar
infiltr
although
pattern
describ
chest
radiograph
also
use
demonstr
presenc
pleural
fluid
frequent
accompani
pneumonia
particularli
bacteri
origin
pleural
fluid
either
thin
serou
thick
purul
latter
case
term
empyema
use
discuss
later
empyema
microscop
examin
sputum
may
play
import
role
evalu
patient
pneumonia
howev
import
obtain
sputum
specimen
use
guid
treatment
oppos
treat
patient
empir
without
sputum
specimen
issu
substanti
controversi
patient
requir
hospit
author
recommend
base
initi
treatment
clinic
present
without
substanti
effort
identifi
caus
organ
contrast
patient
sick
enough
admit
hospit
still
treat
empir
attempt
made
identifi
organ
order
guid
therapi
sputum
specimen
obtain
import
evalu
qualiti
specimen
poor
qualiti
specimen
may
provid
inadequ
inaccur
inform
appropri
sputum
specimen
ie
one
contain
squamou
epitheli
cell
pick
transit
oropharynx
inflammatori
cell
bacteria
seen
bacteri
pneumonia
larg
number
pmn
seen
sputum
contrast
mycoplasm
viral
pneumonia
fewer
pmn
mononuclear
inflammatori
cell
pneumococc
staphylococc
gramneg
bacillari
pneumonia
commonli
demonstr
rel
homogen
popul
infect
bacteria
anaerob
aspir
pneumonia
caus
mixtur
organ
oropharynx
show
mix
popul
bacteria
mani
differ
morpholog
legionnair
diseas
bacterium
stain
well
usual
gram
stain
reagent
gener
requir
special
stain
appreci
presenc
mycoplasm
viral
pneumonia
infect
agent
visual
light
microscopi
predominantli
mononuclear
cell
inflammatori
respons
seen
conjunct
initi
gram
stain
microscop
examin
sputum
specimen
cultur
bacteria
howev
bacteria
rel
difficult
grow
mani
case
initi
gram
stain
import
make
etiolog
diagnosi
special
cultur
media
avail
facilit
growth
legionella
speci
sputum
spontan
expector
patient
method
obtain
respiratori
secret
even
materi
directli
lung
parenchyma
may
necessari
techniqu
usedflex
bronchoscopi
needl
aspir
lung
occasion
surgic
lung
biopsyar
describ
greater
detail
chapter
techniqu
test
urin
presenc
antigen
relat
pneumonia
legionella
see
becom
increasingli
use
routin
stain
cultur
sputum
use
three
import
caus
pneumonia
mycoplasma
chlamydophila
legionella
sometim
diagnosi
confirm
varieti
serolog
techniqu
demonstr
rise
antibodi
titer
organ
techniqu
provid
retrospect
diagnosi
clinic
use
sever
newer
method
see
increas
clinic
use
time
exampl
direct
fluoresc
antibodi
stain
perform
legionella
especi
tissu
specimen
recent
method
includ
cultur
special
supplement
media
commonli
use
urinari
antigen
radioimmunoassay
certain
l
pneumophila
serotyp
nucleic
acid
amplif
method
includ
polymeras
chain
reaction
wide
use
detect
mycoplasma
chlamydophila
specif
respiratori
virus
influenza
coronavirus
function
assess
patient
acut
infecti
pneumonia
usual
limit
evalu
ga
exchang
arteri
blood
ga
valu
characterist
demonstr
hypoxemia
accompani
normal
decreas
pco
well
widen
alveolararteri
aa
oxygen
gradient
pulmonari
function
test
littl
use
set
cornerston
treatment
bacteri
pneumonia
prompt
effect
antibiot
therapi
direct
infect
organ
howev
caus
organ
often
known
pneumonia
first
diagnos
fact
frequent
identifi
point
clinic
cours
initi
treatment
strategi
develop
basi
clinic
set
eg
communityacquir
vs
hospitalacquir
pneumonia
initi
treatment
strategi
outlin
later
initi
manag
strategi
base
clinic
set
pneumonia
organ
identifi
regimen
may
chang
allow
focus
effect
antibiot
coverag
knowledg
antibiot
suscept
specif
organ
help
understand
rational
behind
initi
treatment
strategi
section
first
consid
gener
pattern
antibiot
suscept
major
organ
caus
pneumonia
case
pneumococc
pneumonia
penicillin
appropri
agent
tradit
assum
patient
allerg
penicillin
although
case
variou
degre
resist
penicillin
encount
increas
frequenc
addit
penicillin
effect
common
caus
communityacquir
pneumonia
eg
mycoplasma
pneumonia
c
pneumonia
class
antibiot
broader
spectrum
agent
caus
communityacquir
pneumonia
typic
use
antibiot
initi
includ
macrolid
erythromycin
deriv
azithromycin
quinolon
eg
moxifloxacin
highlevel
resist
pneumococcu
penicillin
found
either
quinolon
vancomycin
typic
necessari
intermedi
resist
strain
often
treat
ceftriaxon
staphylococci
gener
produc
penicillinas
requir
use
penicillinaseresist
semisynthet
deriv
penicillin
oxacillin
nafcillin
mani
staphylococci
also
resist
deriv
case
vancomycin
antibiot
choic
h
influenza
may
sensit
ampicillin
high
frequenc
organ
resist
antibiot
gener
justifi
altern
coverag
secondor
thirdgener
cephalosporin
extendedspectrum
macrolid
trimethoprimsulfamethoxazol
quinolon
inhibitor
combin
mani
gramneg
bacillari
pneumonia
often
display
resist
varieti
antibiot
aminoglycosid
eg
gentamicin
tobramycin
thirdor
fourthgener
cephalosporin
quinolon
carbapenem
eg
meropenem
extendedspectrum
penicillin
inhibitor
eg
piperacillin
tazobactam
may
use
initi
antibiot
sensit
test
perform
pneumonia
caus
anaerob
treat
commonli
either
penicillin
clindamycin
macrolid
quinolon
antibiot
choic
pneumonia
caus
either
legionella
mycoplasma
definit
form
therapi
avail
viral
pneumonia
although
rapid
advanc
field
may
lead
develop
clinic
use
therapeut
agent
influenza
vaccin
see
chapter
effect
prevent
influenza
major
individu
receiv
wherea
antivir
agent
amantadin
rimantadin
influenza
neuraminidas
inhibitor
zanamivir
oseltamivir
influenza
b
may
reduc
durat
sever
ill
given
soon
onset
clinic
symptom
modal
therapi
mainli
support
chest
physic
therapi
measur
assist
clearanc
respiratori
secret
use
patient
pneumonia
particularli
neuromuscular
diseas
factor
impair
effect
patient
cough
patient
inadequ
ga
exchang
demonstr
signific
hypoxemia
administr
supplement
benefici
occasion
frank
respiratori
failur
develop
appropri
support
measur
institut
see
chapter
past
two
decad
greater
emphasi
costeffect
use
medic
resourc
spur
develop
algorithm
guidelin
clinician
approach
common
clinic
problem
pneumonia
particularli
good
exampl
import
clinic
problem
manag
strategi
develop
relat
diagnost
evalu
initi
therapi
separ
strategi
promulg
two
distinct
group
patient
pneumonia
depend
set
pneumonia
develop
communityacquir
nosocomi
hospitalacquir
guidelin
appli
patient
signific
underli
impair
system
host
defens
mechan
patient
aid
receiv
immunosuppress
drug
cancer
chemotherapi
communityacquir
pneumonia
refer
pneumonia
develop
commun
set
ie
individu
hospit
although
categori
meant
includ
patient
signific
impair
system
host
defens
mechan
includ
patient
coexist
ill
risk
factor
alter
profil
organ
like
respons
pneumonia
surprisingli
caus
communityacquir
pneumonia
never
identifi
high
proport
patient
estim
likelihood
particular
agent
believ
influenc
number
modifi
factor
presenc
coexist
ill
recent
treatment
antibiot
resid
nurs
home
sever
ill
initi
present
one
issu
spark
controversi
whether
attempt
made
identifi
specif
etiolog
agent
use
gram
stain
cultur
patient
communityacquir
pneumonia
whether
empir
therapi
use
base
patient
risk
factor
clinic
characterist
local
bacteri
resist
pattern
specif
pathogen
identifi
modif
initi
antibiot
regimen
often
appropri
particularli
avoid
overli
broad
spectrum
coverag
tabl
summar
etiolog
initi
manag
four
broad
subcategori
patient
communityacquir
pneumonia
first
group
compris
patient
coexist
cardiopulmonari
diseas
modifi
risk
factor
use
antibiot
previou
month
requir
hospit
common
pathogen
group
patient
includ
pneumonia
pneumonia
c
pneumonia
respiratori
virus
smoker
h
influenza
prefer
therapeut
regimen
one
advancedgener
macrolid
antibiot
azithromycin
clarithromycin
recommend
subject
local
differ
rate
bacteri
resist
exampl
region
unit
state
pneumonia
isol
resist
macrolid
second
group
includ
patient
coexist
cardiopulmonari
diseas
modifi
risk
factor
still
treat
outpati
set
import
comorbid
place
patient
categori
includ
chronic
heart
lung
hepat
renal
diseas
diabet
mellitu
alcohol
malign
asplenia
immunosuppress
condit
drug
use
antibiot
within
prior
month
case
antibiot
differ
class
use
local
resist
pattern
pneumonia
taken
account
resid
nurs
home
consid
factor
increas
risk
pneumonia
caus
gramneg
organ
poor
dentit
lead
increas
burden
anaerob
organ
mouth
problem
swallow
impair
conscious
increas
risk
anaerob
aspir
pneumonia
recommend
option
manag
group
includ
either
oral
quinolon
use
singl
agent
antibiot
eg
secondor
thirdgener
cephalosporin
given
combin
macrolid
particularli
advancedgener
macrolid
azithromycin
clarithromycin
third
fourth
group
differ
first
two
basi
sever
pneumonia
third
group
defin
need
hospit
fourth
group
includ
patient
sever
diseas
necessit
admiss
intens
care
unit
icu
patient
still
commonli
pneumonia
caus
pneumonia
organ
found
outpati
addit
concern
gramneg
bacilli
legionella
sometim
aureu
therapi
patient
adjust
accordingli
see
tabl
antibiot
quinolon
advancedgener
macrolid
plu
particularli
thirdgener
cephalosporin
carbapenem
extendedspectrum
penicillin
inhibitor
typic
use
set
frequent
combin
vancomycin
increas
data
suggest
adjunct
treatment
corticosteroid
may
benefici
mani
patient
sever
pneumonia
howev
practic
uniformli
adopt
data
suggest
patient
pulmonari
infect
due
influenza
aspergillu
may
wors
outcom
corticosteroid
use
number
score
system
develop
assess
need
hospit
icu
admiss
individu
patient
base
upon
demograph
characterist
sever
ill
present
detail
discuss
algorithm
beyond
scope
chapter
refer
common
clinic
predict
rule
provid
contrast
communityacquir
pneumonia
nosocomi
pneumonia
acquir
hospit
patient
gener
hour
hospit
patient
icu
especi
receiv
mechan
ventil
particularli
high
risk
develop
categori
pneumonia
perhap
common
problem
lead
nosocomi
pneumonia
colon
oropharynx
organ
usual
present
site
follow
microaspir
oropharyng
secret
tracheobronchi
tree
patient
risk
often
underli
medic
problem
receiv
antibiot
endotrach
tube
airway
bypass
normal
protect
mechan
respiratori
tract
gastric
acidreduc
medic
particularli
protonpump
inhibitor
implic
risk
factor
nosocomi
pneumonia
studi
increas
gastric
ph
allow
increas
bacteri
growth
presum
mechan
organ
particular
concern
patient
develop
hospitalacquir
pneumonia
enter
gramneg
bacilli
aureu
organ
pseudomona
aeruginosa
legionella
involv
diagnost
evalu
difficult
often
complic
need
distinguish
bacteri
colon
tracheobronchi
tree
true
bacteri
pneumonia
clinic
issu
involv
diagnost
test
optim
form
therapi
beyond
scope
discuss
found
refer
end
chapter
organ
particular
concern
nosocomi
pneumonia
includ
legionella
part
discuss
pneumonia
two
specif
intrathorac
complic
pneumonialung
abscess
empyemaar
briefli
consid
repres
import
clinic
sequela
lung
abscess
like
abscess
elsewher
repres
local
collect
pu
lung
abscess
gener
result
tissu
destruct
complic
pneumonia
abscess
content
primarili
pmn
often
collect
bacteri
organ
antibiot
administ
organ
may
longer
cultur
abscess
caviti
etiolog
agent
associ
format
lung
abscess
gener
bacteria
caus
signific
tissu
necrosi
commonli
anaerob
organ
respons
suggest
aspir
oropharyng
content
predispos
event
howev
aerob
organ
staphylococcu
enter
gramneg
rod
also
caus
signific
tissu
destruct
cavit
region
lung
parenchyma
abscess
format
treatment
lung
abscess
involv
antibiot
therapi
often
given
longer
uncompl
pneumonia
although
abscess
elsewher
bodi
drain
surgic
incis
lung
abscess
gener
drain
tracheobronchi
tree
surgic
intervent
placement
drainag
cathet
need
rare
pneumonia
extend
pleural
surfac
inflammatori
process
eventu
may
lead
empyema
anoth
intrathorac
complic
pneumonia
term
empyema
properli
empyema
thoraci
refer
pu
pleural
space
florid
form
empyema
repres
thick
creami
yellow
fluid
within
pleural
space
fluid
contain
enorm
number
leukocyt
primarili
pmn
often
accompani
bacteri
organ
true
empyema
often
even
grossli
inflammatori
pleural
effus
accompani
pneumonia
parapneumon
effus
pleural
inflamm
result
format
local
pocket
fluid
substanti
scar
limit
mobil
underli
lung
sever
differ
bacteri
organ
may
associ
develop
empyema
anaerob
particularli
common
staphylococci
aerob
organ
also
potenti
caus
empyema
document
usual
thoracentesi
sampl
pleural
fluid
drainag
fluid
requir
mani
case
thoracoscop
surgeri
perform
complet
drain
pleural
space
altern
techniqu
use
specif
clinic
situat
includ
open
surgic
procedur
placement
largebor
chest
tube
repeat
instil
fibrinolyt
agent
eg
alteplas
dnase
pleural
space
magnitud
societi
concern
bioterror
increas
abruptli
recent
year
recognit
case
cutan
inhal
anthrax
contract
handl
mail
contain
anthrax
spore
unit
state
illustr
vividli
danger
pose
previous
uncommon
biolog
agent
also
widespread
fear
elicit
threat
bioterror
section
briefli
discuss
three
biolog
agent
lifethreaten
effect
mediat
infect
involv
respiratori
system
bacillu
anthraci
yersinia
pesti
francisella
tularensi
bacillu
anthraci
gramposit
sporeform
rod
found
soil
caus
infect
farm
stock
wild
anim
human
case
occur
result
exposur
infect
anim
contamin
anim
product
inhal
aerosol
spore
virul
potenti
lethal
organ
relat
elabor
toxin
caus
promin
edema
inhibit
neutrophil
function
alter
product
number
cytokin
wherea
cutan
anthrax
result
spore
introduc
break
skin
inhal
anthrax
follow
inhal
spore
alveolar
space
transport
viabl
spore
via
lymphat
mediastin
lymph
node
germin
spore
mediastinum
associ
toxin
releas
hemorrhag
lymphaden
mediastin
clinic
patient
inhal
anthrax
typic
present
flulik
ill
symptom
mild
fever
myalgia
nonproduct
cough
malais
chest
discomfort
sever
day
later
becom
acut
sever
ill
fever
dyspnea
cyanosi
septic
shock
often
find
mening
promin
abnorm
chest
radiograph
mediastin
widen
hemorrhag
lymphaden
mediastin
viabl
spore
present
mediastinum
alveoli
anthrax
gener
transmit
person
person
via
droplet
nuclei
despit
treatment
ciprofloxacin
doxycyclin
mortal
extrem
high
onset
clinic
ill
public
health
guidelin
focus
prophylaxi
either
antibiot
prevent
inhal
anthrax
follow
confirm
suspect
exposur
aerosol
spore
anthrax
vaccin
avail
requir
complex
administr
schedul
annual
booster
inject
despit
associ
epidem
devast
proport
black
death
centuri
plagu
uncommon
diseas
howev
plagu
one
condit
thought
major
concern
possibl
weapon
bioterror
caus
organ
yersinia
pesti
gramneg
rod
transmit
flea
rodent
human
still
endem
mani
part
world
includ
southwest
pacif
coastal
region
unit
state
former
soviet
union
focus
area
africa
asia
south
america
infect
skin
dissemin
region
lymph
node
lead
clinic
syndrom
bubon
plagu
infect
lung
pneumon
plagu
occur
either
secondari
bacterem
spread
skin
lymph
node
via
airborn
transmiss
organ
person
person
pneumon
plagu
highli
contagi
aerosol
organ
cough
pulmonari
involv
character
widespread
bronchopneumonia
region
homogen
consolid
clinic
patient
becom
acut
ill
high
fever
malais
myalgia
rigor
dyspnea
cyanosi
chest
radiographi
show
widespread
bronchopneumonia
diffus
pattern
resembl
acut
respiratori
distress
syndrom
ard
mortal
high
unless
antibiot
treatment
initi
soon
onset
symptom
streptomycin
doxycyclin
treatment
choic
tularemia
caus
francisella
tularensi
gramneg
coccobacillari
organ
infect
small
mammal
transmit
human
insect
vector
eg
tick
exposur
contamin
anim
inhal
aerosol
organ
although
sever
differ
form
clinic
present
may
occur
tularemia
depend
mechan
transmiss
site
entri
pulmonari
tularemia
secondari
inhal
f
tularensi
primari
concern
use
organ
bioterrorist
weapon
pulmonari
tularemia
character
patchi
inflamm
consolid
lung
parenchyma
sometim
enlarg
hilar
lymph
node
develop
pleural
effus
patient
develop
fever
chill
malais
headach
chest
radiographi
show
patchi
consolid
may
accompani
hilar
lymphadenopathi
pleural
effus
treatment
consist
streptomycin
mortal
estim
approxim
without
treatment
